Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.

Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, Zendehdel N, Rakhshani N, Stolte M, Mirzaei M, Saliminejhad M, Saeidi S, Shahidi M.

Arch Iran Med. 2012 Nov;15(11):664-9. doi: 0121511/AIM.004.

2.

Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.

Ito M, Haruma K, Kamada T, Mihara M, Kim S, Kitadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K.

Aliment Pharmacol Ther. 2002 Aug;16(8):1449-56.

3.

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A.

Gut. 2004 Jan;53(1):12-20.

4.

Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.

Ciok J, Dzieniszewski J, Lucer C.

J Physiol Pharmacol. 1997 Sep;48 Suppl 4:115-22.

PMID:
9440062
5.

Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication.

Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, Shiota S, Nakagawa Y, Mizukami K, Fujioka T.

J Gastroenterol. 2012 Apr;47(4):394-403. doi: 10.1007/s00535-011-0504-9. Epub 2011 Dec 6.

PMID:
22138891
6.

Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.

Ohkusa T, Fujiki K, Takashimizu I, Kumagai J, Tanizawa T, Eishi Y, Yokoyama T, Watanabe M.

Ann Intern Med. 2001 Mar 6;134(5):380-6.

PMID:
11242498
7.
8.

Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation.

Kodama M, Murakami K, Okimoto T, Abe T, Nakagawa Y, Mizukami K, Uchida M, Inoue K, Fujioka T.

Digestion. 2012;85(2):126-30. doi: 10.1159/000334684. Epub 2012 Jan 19.

PMID:
22269293
9.

[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].

Walecka-Kapica E, Knopik-Dabrowicz A, Klupińska G, Chojnacki J.

Pol Merkur Lekarski. 2008 Feb;24(140):95-100. Polish.

PMID:
18634262
10.

Topography of gastritis and its severity in 864 first degree relatives of gastric cancer patients.

Zendehdel N, Massarrat S, Sheykholeslami A, Rakhshani N, Saeidi S, Rafiee R, Nobakht H, Tabib SM, Saliminejhad M, Dooghaie Moghadam M, Nasiri J, Azimi K, Fakhar R, Babaei M, Didehvar R, Mohammadi N, Tavazoee M, Malekzadeh R.

Arch Iran Med. 2010 Nov;13(6):469-75. doi: 010136/AIM.004.

11.

Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.

Toyokawa T, Suwaki K, Miyake Y, Nakatsu M, Ando M.

J Gastroenterol Hepatol. 2010 Mar;25(3):544-7. doi: 10.1111/j.1440-1746.2009.05995.x. Epub 2009 Oct 6.

PMID:
19817964
12.

Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea.

Kang JM, Kim N, Shin CM, Lee HS, Lee DH, Jung HC, Song IS.

Helicobacter. 2012 Apr;17(2):86-95. doi: 10.1111/j.1523-5378.2011.00918.x.

PMID:
22404438
13.

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8.

PMID:
11106679
14.

Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.

Tahara T, Shibata T, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Kamiya Y, Ishizuka T, Nakagawa Y, Nagasaka M, Iwata M, Nakamura M, Hirata I, Arisawa T.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2416-20. doi: 10.5754/hge10605.

PMID:
23169178
15.

Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?

Kyzekové J, Arlt J, Arltová M.

Hepatogastroenterology. 2001 Mar-Apr;48(38):594-602.

PMID:
11379362
16.

H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.

Yang HB, Sheu BS, Wang ST, Cheng HC, Chang WL, Chen WY.

Am J Gastroenterol. 2009 Jul;104(7):1642-9. doi: 10.1038/ajg.2009.172. Epub 2009 May 12.

PMID:
19436275
17.

A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.

Zhou L, Sung JJ, Lin S, Jin Z, Ding S, Huang X, Xia Z, Guo H, Liu J, Chao W.

Chin Med J (Engl). 2003 Jan;116(1):11-4.

PMID:
12667379
18.

Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.

Cho SJ, Choi IJ, Kook MC, Yoon H, Park S, Kim CG, Lee JY, Lee JH, Ryu KW, Kim YW.

Aliment Pharmacol Ther. 2013 Sep;38(5):477-89. doi: 10.1111/apt.12402. Epub 2013 Jul 3.

19.

Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at inner-city hospitals in New York.

Steenport M, Eom H, Uezu M, Schneller J, Gupta R, Mustafa Y, Villanueva R, Straus EW, Raffaniello RD.

Oncol Rep. 2007 Jul;18(1):235-40.

PMID:
17549373
20.

A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population.

Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agréus L.

Scand J Gastroenterol. 2005 Mar;40(3):302-11.

PMID:
15932171

Supplemental Content

Support Center